EXICURE, INC. Long-Term Debt, Maturity, Year One
EXICURE, INC. (XCUR) had Long-Term Debt, Maturity, Year One of $625.00 thousand as of 2021-12-31, per its 10-K filed 2022-03-25.
Discontinued › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths · last filed 2022-03-25
- 2021-12-31: Long-Term Debt, Maturity, Year One $625.00K.
- 2021-09-30: Long-Term Debt, Maturity, Year One $1.46M.
- 2021-06-30: Long-Term Debt, Maturity, Year One $1.46M.
- 2021-03-31: Long-Term Debt, Maturity, Year One $1.46M.
| Period end | Long-Term Debt, Maturity, Year One |
|---|---|
| 2021-12-31 | $625.00K 10-K · filed 2022-03-25 |
| 2021-09-30 | $1.46M 10-Q · filed 2021-11-19 |
| 2021-06-30 | $1.46M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $1.46M 10-Q · filed 2021-05-12 |
| 2020-12-31 | $0.00 10-K · filed 2021-03-11 |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-12 |
| 2019-12-31 | $5.00M 10-K · filed 2020-03-10 |
| 2018-12-31 | $0.00 10-K/A · filed 2019-09-23 |
| 2017-12-31 | $0.00 10-K · filed 2018-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |